Insider Stock Trading History of Ubs Oncology Impact Fund L.p.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Ubs Oncology Impact Fund L.p. since year 2005. The trader's CIK number is 1691428. At the time of this reporting, Ubs Oncology Impact Fund L.p. is the of Sunesis Pharmaceuticals Inc . (stock ticker symbol SNSS). See this page for all insider trading activities at Sunesis Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Ubs Oncology Impact Fund L.p. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-11-06 SNSS Sunesis Pharmaceuticals Inc Buy 16,200 2.77 44,874
2017-11-03 SNSS Sunesis Pharmaceuticals Inc Buy 40,000 2.89 115,600
2017-11-02 SNSS Sunesis Pharmaceuticals Inc Buy 25,300 2.59 65,527

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ubs Oncology Impact Fund L.p. ( of Sunesis Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.